Increased expression of gamma-aminobutyric acid transporter-1 in the forebrain of infant rats with corticotropin-releasing hormone-induced seizures but not in those with hyperthermia-induced seizures
Introduction
The majority of seizures occurring in the developing human are not spontaneous; i.e., they are not related to inherent abnormalities in the balance of neuronal excitation and inhibition. Instead, most developmental seizures are provoked by injurious or stressful stimuli (Baram and Hatalski, 1998). Thus, seizures during development may be induced by hypoxia (Jensen et al., 1998) or fever (see Baram et al., 1997b for review). Febrile seizures represent an important type of developmental seizure. They are extremely common in the human and have been modeled in the immature rat (Baram et al., 1997b, Toth et al., 1998, Chen et al., 1999, Dube et al., 2000). The mechanisms by which these stressful stimuli cause seizures are not clear. However, recently a role for the stress-activated excitatory neuropeptide, corticotropin-releasing hormone (CRH)(Vale et al., 1981), has been suggested in developmental seizures (Baram and Hatalski, 1998). Stress activates the expression of CRH in several brain regions that are involved in the circuitry for stressful stimuli (Hatalski et al., 1998). The limbic system, particularly the amygdala and hippocampus, is rich in neuronal populations that either synthesize CRH or possess CRH receptors (Swanson et al., 1983, De Souza et al., 1985, Avishai-Eliner et al., 1996). CRH functions as an excitatory neuromodulator (Aldenhoff et al., 1983, Ehlers et al., 1983, Hollrigel et al., 1998). In fact, picomolar amounts of CRH induce severe and prolonged seizures within minutes in young rats (Baram and Schultz, 1991, Baram et al., 1992, Baram and Schultz, 1995). Furthermore, repeated administration of CRH doses (150 × 10−12 mole), which results in status epilepticus, leads to enhanced excitability of the limbic circuit (Baram and Hatalski, 1998) and to excitotoxic injury in select hippocampal and amygdala neurons in the infant rat (Baram and Ribak, 1995, Ribak and Baram, 1996). This information suggests that some stressors (i.e., hypoxia and hyperthermia) may provoke seizures early in life by increasing the levels of CRH in limbic structures. CRH-induced seizures are a model of developmental seizures because they are far more robust during the second posnatal week in rats than in adults (Baram et al., 1992, Baram and Hatalski, 1998). This may be partially due to high levels of the CRH receptor in limbic regions at this time (Avishai-Eliner et al., 1996).
Many previous neurophysiological studies have indicated that a failure of inhibition is a principal reason for neuronal hyperexcitability during epileptic seizures (Gean et al., 1989, Kamphuis et al., 1987, Kapur et al., 1989, Morimoto et al., 1987a, Morimoto et al., 1987b, Ribak, 1991). Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system. Extracellular GABA concentrations in the synaptic cleft are regulated by the activity of GABAergic neurons and by specific Na+ dependent transporter proteins on presynaptic terminals and glial cells involved in GABA uptake (Iversen and Kelly, 1975). Molecular studies have revealed at least four subtypes of GABA transporters: GAT-1, GAT-2, GAT-3 and BGT-1 (Borden et al., 1992, Guastella et al., 1990, Clark et al., 1992). These transporters have several possible functional roles, including the inactivation of GABA's action in synaptic transmission by removing GABA from the vicinity of its receptors (Iversen and Kelly, 1975, Schousboe, 1981, Isaacson et al., 1993).
GAT-1 has been demonstrated within neurons and astrocytes in various regions of the rat brain, including the olfactory bulb, neocortex, hippocampus, ventral pallidum and cerebellum (Durkin et al., 1995, Minelli et al., 1995, Ribak et al., 1996). The neuronal localization of GAT-1 in the adult hippocampus is exclusively within axon terminals forming symmetric synapses, including those from GABAergic basket and chandelier cells (Ribak et al., 1978, Ribak et al., 1996). In young rats at 10–30 postnatal days (PND) of age, GAT-1 is also localized to the somata and dendrites of GABAergic interneurons in the neocortex and hippocampus (Yan et al., 1997). The number of labeled somata varied with the age of the rat during this period. A role for GATs in adult seizures has been established (Akbar et al., 1998, During et al., 1995, Hirao et al., 1998, Mathern et al., 1999). Here we tested the hypothesis that seizures influence the normal distribution of GAT-1-immunolabeling in the immature brain. Thus, the present study addresses the question of whether an alteration in transporter distribution occurred after two types of developmental seizures: CRH-induced and hyperthermia-induced seizures. Immunocytochemical techniques were used to assess regional differences in the number of GAT-1 labeled neurons in rats with both types of seizure, and those data were compared to that of vehicle-treated controls.
Section snippets
Animals
Rats were the offspring of time-pregnant, Sprague-Dawley dams. Rats were born in our federally approved animal facility and were kept on a 12 h light/dark cycle. The time of birth of the pups were determined every 12 h, and the day of birth was considered day 0. Litters were culled to 12 pups and mixed among experimental groups. Cages were maintained in a quiet room, and were undisturbed for 24 h prior to experiments.
CRH-infusions
Pups [10 postnatal days of age (PND)] were implanted with cannulae 24 h prior
Hippocampal formation
The regional immunolabeling pattern for GAT-1 in control brains was similar to that described previously for the hippocampal formation and neocortex in young rats (Yan et al., 1997). GAT-1-immunoreactivity (ir) in the dentate gyrus was dense in the molecular layer and lighter in the hilus where mainly unlabeled mossy fibers were found. The somata of unlabeled hippocampal principal neurons, granule and pyramidal cells, were outlined by small immunolabeled puncta (Fig. 1A and C, Fig. 2A and B).
Discussion
The results of this study indicate that GAT-1-ir is altered by CRH-induced seizures but not by hyperthermia or hyperthermia-induced seizures. Changes induced by CRH seizures appear to depend on the time following CRH infusion and are region specific. Our data showed significant increases in the number of detectable GAT-1-ir neuronal somata in specific forebrain areas in the 24 h CRH group as compared to the control group. However, the number of neurons with GAT-1-ir was not altered in either
Acknowledgements
The authors gratefully acknowledge Dr Nicholas Brecha for providing the GAT-1 antibody and Dr Tallie Z. Baram for her support and critical discussions of this work. This work was supported by the UC-Systemwide Biotechnology Research and Education Program (98-02 to TZB) and National Institutes of Health grants NS-38331 (to CER), NS-28912 and NS-35439 (to TZB).
References (50)
- et al.
Reduction of GABA and glutamate transporter messenger RNAs in the severe-seizure genetically epilepsy-prone rat
Neurosci.
(1998) - et al.
The time of origin of cells demonstrating glutamic acid decarboxylase-like immunoreactivity in the hippocampal formation of the rat
Neurosci. Lett.
(1985) - et al.
Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system
Dev. Brain Res.
(1996) - et al.
Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat
Dev. Brain Res.
(1991) - et al.
The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain in vivo evidence using a novel, selective non-peptide CRF receptor antagonist
Brain Res.
(1997) - et al.
Febrile seizures: an appropriate-aged model suitable for long term studies
Dev. Brain Res.
(1997) - et al.
Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain
Trnds. Neurosci.
(1998) - et al.
Molecular heterogeneity of the gamma-aminobutyric acid (GABA) transport system
J. Biol. Chem.
(1992) - et al.
The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation
Dev. Brain Res.
(1998) - et al.
Functional expression and CNS distribution of beta- alanine-sensitive neuronal GABA transporter
Neuron.
(1992)
Localization of messengers RNAs encoding three GABA transporters in rat brain: an in situ hybridization study
Mol. Brain Res.
Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats
Brain Res.
Spontaneous epileptiform activity and alteration of GABA- and of NMDA-mediated neurotransmission in amygdala neurons kindled in vivo
Brain Res.
Time dependent and regional expression of GABA transporter mRNAs following amygdala-kindled seizures in rats
Mol. Brain Res.
The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats
Neurosci.
Local and diffuse synaptic actions of GABA in the hippocampus
Neuron
Uptake and metabolism of gamma-aminobutyric acid by neurons and glial cells
Biochem. Pharmacol.
The development of changes in hippocampal GABA immunoreactivity in the rat kindling model of epilepsy: a light microscopic study with GABA antibodies
Neurosci.
Evidence for a chronic loss of inhibition in the hippocampus after kindling. Biochemical studies
Epilepsy Res.
Kindling-induced changes in the EEG recorded during stimulation from the site of stimulation. II. Comparison between spontaneous and evoked potentials
Exp. Neurol.
Kindling-induced changes in EEG recorded during stimulation from the site of stimulation III. Direct pharmacological manipulations of the kindled amygdala
Exp. Neurol.
Effects of vigabatrin treatment on status epilepticus-induced neuronal damage and mossy fiber sprouting in the rat hippocampus
Epilepsy Res.
Immunocytochemical localization of glutamic acid decarboxylase in neuronal somata following colchicine inhibition of axonal transport
Brain Res.
Selective death of hippocampal CA3 pyramidal cells with mossy fiber afferents after CRH-induced status epilepticus in infant rats
Dev. Brain Res.
Transport and metabolism of glutamate and GABA in neurons are glial cells
Int. Rev. Neurobiol.
Cited by (10)
Up-regulation of GABA transporters and GABA<inf>A</inf> receptor α1 subunit in tremor rat hippocampus
2010, Neuroscience LettersNeuronal localization of the GABA transporter GAT-3 in human cerebral cortex: A procedural artifact?
2005, Journal of Chemical NeuroanatomyGABA transporters in the mammalian cerebral cortex: Localization, development and pathological implications
2004, Brain Research ReviewsGlial GABA transporters as modulators of inhibitory signalling in epilepsy and stroke
2017, Advances in Neurobiology